SAFETY DATA SHEET

Lynestrenol Formulation
Version
9.0

Revision Date:
2024/04/06

SDS Number:
449552-00019

Date of last issue: 2023/09/30
Date of first issue: 2016/01/15

1. PRODUCT AND COMPANY IDENTIFICATION
Chemical product name:Lynestrenol Formulation

Supplier's company name, address and phone number
Company name of supplier: Organon & Co.
Address:

30 Hudson Street, 33nd floor
Jersey City, New Jersey, U.S.A 07302

Telephone:+1-551-430-6000

E-mail address:

EHSSTEWARD@organon.com

Emergency telephone number :+1-215-631-6999

Recommended use of the chemical and restrictions on use
Recommended use: Pharmaceutical
Restrictions on use: Not applicable

2. HAZARDS IDENTIFICATIONGHS classification of chemical productGerm cell mutagenicity: Category 1B
Carcinogenicity:

Category 2

Reproductive toxicity:

Category 1ASpecific target organ toxicity repeated exposure:

Category 2 (Blood, Mammary gland, Uterus (including cervix),
Ovary)

GHS label elements
Hazard pictograms:

Signal word:

DangerHazard statements:

H340 May cause genetic defects.
H351 Suspected of causing cancer.
H360Fd May damage fertility. Suspected of damaging the unborn child.
H373 May cause damage to organs (Blood, Mammary gland,
Uterus (including cervix), Ovary) through prolonged or repeatedexposure.
1 / 19SAFETY DATA SHEET

Lynestrenol Formulation
Version
9.0

Revision Date:
2024/04/06

SDS Number:
449552-00019

Precautionary statements:

Date of last issue: 2023/09/30
Date of first issue: 2016/01/15

Prevention:
P201 Obtain special instructions before use.
P202 Do not handle until all safety precautions have been readand understood.
P260 Do not breathe dust.
P280 Wear protective gloves/ protective clothing/ eye protection/ face protection.
Response:
P308 + P313 IF exposed or concerned: Get medical advice/attention.
Storage:
P405 Store locked up.
Disposal:
P501 Dispose of contents/ container to an approved waste
disposal plant.

Other hazards which do not result in classification
Important symptoms and out- : Dust contact with the eyes can lead to mechanical irritation.
lines of the emergency asContact with dust can cause mechanical irritation or drying ofsumed
the skin.
May form explosive dust-air mixture during processing, handling or other means.
3. COMPOSITION/INFORMATION ON INGREDIENTS
Substance / Mixture:

MixtureComponents
Chemical nameStarchCAS-No.
9005-25-8

Concentration (% w/w)>= 20 - < 30

ENCS No.
8-98

Lynestrenol
Talc

52-76-6
14807-96-6>= 1 - < 10
> 0 - < 10

1-468

Tocopherol

10191-41-0>= 0.1 - < 1

9-864

4. FIRST AID MEASURES
General advice:

If inhaled:

In case of skin contact:

In the case of accident or if you feel unwell, seek medical advice immediately.
When symptoms persist or in all cases of doubt seek medical
advice.
If inhaled, remove to fresh air.
Get medical attention.
In case of contact, immediately flush skin with soap and plenty
2 / 19SAFETY DATA SHEET

Lynestrenol Formulation
Version
9.0

Revision Date:
2024/04/06

SDS Number:
449552-00019

In case of eye contact:

If swallowed:

Most important symptoms
and effects, both acute anddelayed:Protection of first-aiders:

Notes to physician:

Date of last issue: 2023/09/30
Date of first issue: 2016/01/15

of water.
Remove contaminated clothing and shoes.
Get medical attention.
Wash clothing before reuse.
Thoroughly clean shoes before reuse.
If in eyes, rinse well with water.
Get medical attention if irritation develops and persists.
If swallowed, DO NOT induce vomiting.
Get medical attention.
Rinse mouth thoroughly with water.
May cause genetic defects.
Suspected of causing cancer.
May damage fertility. Suspected of damaging the unborn
child.
May cause damage to organs through prolonged or repeatedexposure.
Contact with dust can cause mechanical irritation or drying of
the skin.
Dust contact with the eyes can lead to mechanical irritation.
First Aid responders should pay attention to self-protection,and use the recommended personal protective equipment
when the potential for exposure exists (see section 8).
Treat symptomatically and supportively.

5. FIREFIGHTING MEASURES
Suitable extinguishing media:

Water spray
Alcohol-resistant foam
Carbon dioxide (CO2)
Dry chemical
None known.

Unsuitable extinguishingmedia
Specific hazards during firefighting::

Avoid generating dust; fine dust dispersed in air in sufficientconcentrations, and in the presence of an ignition source is apotential dust explosion hazard.
Exposure to combustion products may be a hazard to health.

Hazardous combustion products:

Carbon oxides

Specific extinguishing methods:

Special protective equipment
for firefighters:

Use extinguishing measures that are appropriate to local circumstances and the surrounding environment.
Use water spray to cool unopened containers.
Remove undamaged containers from fire area if it is safe to doso.
Evacuate area.
In the event of fire, wear self-contained breathing apparatus.
Use personal protective equipment.

6. ACCIDENTAL RELEASE MEASURES
Personal precautions, protec- :tive equipment and emer-

Use personal protective equipment.
Follow safe handling advice (see section 7) and personal pro3 / 19

SAFETY DATA SHEET

Lynestrenol Formulation
Version
9.0

Revision Date:
2024/04/06

SDS Number:
449552-00019

gency procedures

Date of last issue: 2023/09/30
Date of first issue: 2016/01/15

tective equipment recommendations (see section 8).

Environmental precautions:

Avoid release to the environment.
Prevent further leakage or spillage if safe to do so.
Retain and dispose of contaminated wash water.
Local authorities should be advised if significant spillages
cannot be contained.

Methods and materials forcontainment and cleaning up:

Sweep up or vacuum up spillage and collect in suitable container for disposal.
Avoid dispersal of dust in the air (i.e., clearing dust surfaces
with compressed air).
Dust deposits should not be allowed to accumulate on surfaces, as these may form an explosive mixture if they are released into the atmosphere in sufficient concentration.
Local or national regulations may apply to releases and disposal of this material, as well as those materials and items
employed in the cleanup of releases. You will need to determine which regulations are applicable.
Sections 13 and 15 of this SDS provide information regarding
certain local or national requirements.

Handling
Technical measures:

Local/Total ventilation:

Advice on safe handling:

Avoidance of contact
Hygiene measures::

Static electricity may accumulate and ignite suspended dust
causing an explosion.
Provide adequate precautions, such as electrical grounding
and bonding, or inert atmospheres.
If sufficient ventilation is unavailable, use with local exhaust
ventilation.
Do not get on skin or clothing.
Do not breathe dust.
Do not swallow.
Avoid contact with eyes.
Wash skin thoroughly after handling.
Handle in accordance with good industrial hygiene and safety
practice, based on the results of the workplace exposure assessment
Keep container tightly closed.
Minimize dust generation and accumulation.
Keep container closed when not in use.
Keep away from heat and sources of ignition.
Take precautionary measures against static discharges.
Do not eat, drink or smoke when using this product.
Take care to prevent spills, waste and minimize release to theenvironment.
Oxidizing agents
If exposure to chemical is likely during typical use, provide eye
flushing systems and safety showers close to the working

7. HANDLING AND STORAGE

4 / 19SAFETY DATA SHEET

Lynestrenol Formulation
Version
9.0

Revision Date:
2024/04/06

SDS Number:
449552-00019

Date of last issue: 2023/09/30
Date of first issue: 2016/01/15

place.
When using do not eat, drink or smoke.
Wash contaminated clothing before re-use.
The effective operation of a facility should include review ofengineering controls, proper personal protective equipment,
appropriate degowning and decontamination procedures,industrial hygiene monitoring, medical surveillance and theuse of administrative controls.
Storage
Conditions for safe storage:

Materials to avoid:

Packaging material:

Keep in properly labelled containers.
Store locked up.
Keep tightly closed.
Store in accordance with the particular national regulations.
Do not store with the following product types:
Strong oxidizing agents
Unsuitable material: None known.

8. EXPOSURE CONTROLS/PERSONAL PROTECTION
Threshold limit value and permissible exposure limits for each component in the work environment
Components

CAS-No.

Value type
(Form ofexposure)

StarchLynestrenol

9005-25-8
52-76-6

Talc

14807-96-6

TWA
TWA
Wipe limit
OEL-M(Respirable
particulatematter)OEL-M (Total
particulatematter)
TWA (Respirable particulate matter)

Engineering measures:

Control parameters / Reference
concentration /Permissible concentration
10 mg/m3
1 µg/m3 (OEB 4)
10 µg/100 cm²
1 mg/m3Basis

4 mg/m3

JP OEL
JSOH

2 mg/m3

ACGIH

ACGIH
Internal
Internal
JP OEL
JSOH

Containment technologies suitable for controlling compounds
are required to control at source and to prevent migration of
the compound to uncontrolled areas (e.g., vacuum conveying
from a closed system, packout head with inflatable seal fromstationary container, ventilated enclosure, etc.).
All engineering controls should be implemented by facility
design and operated in accordance with GMP principles toprotect products, workers, and the environment.
5 / 19SAFETY DATA SHEET

Lynestrenol Formulation
Version
9.0

Revision Date:
2024/04/06

SDS Number:
449552-00019

Date of last issue: 2023/09/30
Date of first issue: 2016/01/15

Essentially no open handling permitted.
Use closed processing systems or containment technologies.
Personal protective equipment
Respiratory protection: If adequate local exhaust ventilation is not available or exposure assessment demonstrates exposures outside the recommended guidelines, use respiratory protection.
Filter type
: Combined particulates and organic vapour type
Hand protection
Material:

Chemical-resistant gloves

Remarks
Eye protection::

Skin and body protection:

Consider double gloving.
Wear safety glasses with side shields or goggles.
If the work environment or activity involves dusty conditions,mists or aerosols, wear the appropriate goggles.
Wear a faceshield or other full face protection if there is apotential for direct contact to the face with dusts, mists, oraerosols.
Work uniform or laboratory coat.
Additional body garments should be used based upon thetask being performed (e.g., sleevelets, apron, gauntlets, disposable suits) to avoid exposed skin surfaces.
Use appropriate degowning techniques to remove potentiallycontaminated clothing.

9. PHYSICAL AND CHEMICAL PROPERTIES
Physical state:

powderColour:No data available

Odour

:

No data available

Odour Threshold:

No data available

Melting point/freezing point:

No data available

Boiling point, initial boilingpoint and boiling range:

No data available

Flammability (solid, gas):

May form explosive dust-air mixture during processing, handling or other means.

Flammability (liquids):

No data available

Lower explosion limit and upper explosion limit / flammability limit
Upper explosion limit / Up- : No data available
per flammability limit
Lower explosion limit /Lower flammability limit:

No data available

6 / 19SAFETY DATA SHEET

Lynestrenol Formulation
Version
9.0

Revision Date:
2024/04/06

SDS Number:
449552-00019

Flash point:

Not applicable

Decomposition temperature:

No data available

pH:

No data available

Evaporation rate:

Not applicableAuto-ignition temperature:

No data available

Viscosity
Viscosity, kinematic:

Not applicable

Solubility(ies)
Water solubility:

No data available

Partition coefficient: noctanol/water:

Not applicable

Vapour pressure:

Not applicable

Density and / or relative density
Relative density:
Density

Date of last issue: 2023/09/30
Date of first issue: 2016/01/15

No data available:

No data available

Relative vapour density:

Not applicable

Explosive properties:

Not explosive

Oxidizing properties:

The substance or mixture is not classified as oxidizing.

Particle characteristics
Particle size:

No data available

Reactivity
Chemical stability
Possibility of hazardous reactions:::

Not classified as a reactivity hazard.
Stable under normal conditions.
May form explosive dust-air mixture during processing, handling or other means.
Can react with strong oxidizing agents.

Conditions to avoid:

Incompatible materials
Hazardous decomposition
products::

Heat, flames and sparks.
Avoid dust formation.
Oxidizing agents
No hazardous decomposition products are known.

10. STABILITY AND REACTIVITY

7 / 19SAFETY DATA SHEET

Lynestrenol Formulation
Version
9.0

Revision Date:
2024/04/06

SDS Number:
449552-00019

Date of last issue: 2023/09/30
Date of first issue: 2016/01/15

11. TOXICOLOGICAL INFORMATION
Information on likely routes of :exposure

Inhalation
Skin contact
Ingestion
Eye contact

Acute toxicity
Not classified based on available information.
Product:
Acute oral toxicity:

Acute toxicity estimate: > 2,000 mg/kg
Method: Calculation method

Starch:Acute oral toxicity:

LD50 (Rat): > 5,000 mg/kg

Acute dermal toxicity:

LD50 (Rabbit): > 2,000 mg/kg

Lynestrenol:
Acute oral toxicity:

LD50: > 1,000 - 8,000 mg/kg

Components:

Acute toxicity (other routes of :administration)

LD50 (Mouse): 110 mg/kg
Application Route: Intraperitoneal

Talc:
Acute oral toxicity:

LD50 (Rat): > 5,000 mg/kg
Remarks: Based on data from similar materials

Tocopherol:
Acute oral toxicity:

LD50 (Rat): > 4,000 mg/kg

Acute dermal toxicity:

LD50 (Rat): > 3,000 mg/kg
Assessment: The substance or mixture has no acute dermal
toxicity

Skin corrosion/irritation
Not classified based on available information.
Components:
Talc:
SpeciesResult::RabbitNo skin irritation

Tocopherol:
8 / 19SAFETY DATA SHEET

Lynestrenol Formulation
Version
9.0

Revision Date:
2024/04/06

Species
MethodResultSDS Number:
449552-00019:::

Date of last issue: 2023/09/30
Date of first issue: 2016/01/15

RabbitOECD Test Guideline 404
No skin irritation

Serious eye damage/eye irritation
Not classified based on available information.
Components:
Starch:SpeciesResult::RabbitNo eye irritation

Talc:
SpeciesResult::RabbitNo eye irritation

Tocopherol:
SpeciesResult
Method:::RabbitNo eye irritation
OECD Test Guideline 405

Respiratory or skin sensitisation
Skin sensitisation
Not classified based on available information.
Respiratory sensitisation
Not classified based on available information.
Components:
Starch:Test Type
Exposure routes
SpeciesResult::::Maximisation Test
Skin contact
Guinea pig
negative

Talc:
Exposure routes
SpeciesResult:::Skin contact
Humansnegative

Tocopherol:
Test Type
Exposure routes
Species
MethodResult:::::Local lymph node assay (LLNA)
Skin contact
Mouse
OECD Test Guideline 429
positive
9 / 19SAFETY DATA SHEET

Lynestrenol Formulation
Version
9.0

Revision Date:
2024/04/06

Assessment

SDS Number:
449552-00019

Date of last issue: 2023/09/30
Date of first issue: 2016/01/15:

Probability or evidence of low to moderate skin sensitisation
rate in humans

Starch:Genotoxicity in vitro:

Test Type: Bacterial reverse mutation assay (AMES)
Result: negative

Lynestrenol:
Genotoxicity in vitro:

Test Type: Chromosome aberration test in vitro
Result: positive

Germ cell mutagenicity
May cause genetic defects.
Components:

Test Type: sister chromatid exchange assay
Result: positive
Genotoxicity in vivo:

Test Type: Mutagenicity (in vivo mammalian bone-marrowcytogenetic test, chromosomal analysis)
Species: Mouse
Application Route: Intraperitoneal injection
Result: positive
Test Type: sister chromatid exchange assay
Species: Mouse
Application Route: Intraperitoneal injection
Result: positive
Test Type: dominant lethal test
Species: Mouse
Application Route: Intraperitoneal
Result: positive

Germ cell mutagenicity Assessment:

Positive result(s) from in vivo somatic cell mutagenicity tests in
mammals. Evidence that the substance has potential to cause
mutations to germ cells

Talc:
Genotoxicity in vitro:

Test Type: DNA damage and repair, unscheduled DNA synthesis in mammalian cells (in vitro)
Result: negative

Genotoxicity in vivo:

Test Type: Chromosome aberration test in vitro
Species: Rat
Application Route: Ingestion
Result: negative

10 / 19

SAFETY DATA SHEET

Lynestrenol Formulation
Version
9.0

Revision Date:
2024/04/06

SDS Number:
449552-00019

Date of last issue: 2023/09/30
Date of first issue: 2016/01/15

Tocopherol:
Genotoxicity in vitro:

Test Type: Chromosome aberration test in vitro
Method: OECD Test Guideline 473
Result: negative
Remarks: Based on data from similar materials

Genotoxicity in vivo:

Test Type: Mammalian erythrocyte micronucleus test (in vivo
cytogenetic assay)
Species: Mouse
Application Route: Ingestion
Result: negative
Remarks: Based on data from similar materials

Lynestrenol:
Species
Application RouteExposure time
ResultTumor Type
Remarks

:
:
:
:
:
:

Mouse
Oral
80 weeks
positive
breast tumors, Liver
Benign and malignant tumor(s)Species
Application RouteExposure time
ResultTumor Type

:
:
:
:
:

Rat
Oral
80 weeks
positive
breast tumors

Carcinogenicity - Assessment:

Limited evidence of carcinogenicity in animal studies

Talc:
Species
Application RouteExposure time
Result

:
:
:
:

Mouse
inhalation (dust/mist/fume)
2 Years
negative

Tocopherol:
Species
Application RouteExposure time
ResultRemarks

:
:
:
:
:

Rat
Ingestion
104 weeks
negative
Based on data from similar materials

Carcinogenicity
Suspected of causing cancer.
Components:

Reproductive toxicity
May damage fertility. Suspected of damaging the unborn child.
11 / 19

SAFETY DATA SHEET

Lynestrenol Formulation
Version
9.0

Revision Date:
2024/04/06

SDS Number:
449552-00019

Date of last issue: 2023/09/30
Date of first issue: 2016/01/15

Components:
Lynestrenol:
Effects on fertility:

Test Type: Fertility/early embryonic development
Species: Rat, males
Application Route: Oral
Fertility: LOAEL: 20 mg/kg body weight
Remarks: Impaired spermatogenesis
Test Type: Fertility/early embryonic development
Species: Rat, females
Application Route: Oral
Fertility: LOAEL: 375 µg/kg
Result: Maternal toxicity observed., Effects on fertility
Test Type: Fertility/early embryonic development
Species: Rabbit
Application Route: Oral
Fertility: LOAEL: 1,300 µg/kg
Result: Effects on fertility, Postimplantation loss.

Effects on foetal development:

Test Type: Embryo-foetal development
Species: Rat
Application Route: Oral
Developmental Toxicity: LOAEL: 0.1 mg/kg body weight
Result: Effects on foetal development
Test Type: Embryo-foetal development
Species: Rabbit
Application Route: Oral
Developmental Toxicity: LOAEL: 0.1 mg/kg body weight
Result: Effects on foetal development, Postimplantation loss.

Reproductive toxicity - Assessment:

Some evidence of adverse effects on development, based onanimal experiments., Positive evidence of adverse effects on
sexual function and fertility from human epidemiological studies.

Talc:
Effects on foetal development:

Test Type: Embryo-foetal development
Species: Rat
Application Route: Ingestion
Result: negative

Tocopherol:
Effects on foetal development:

Test Type: Embryo-foetal development
Species: Rabbit
Application Route: Ingestion
Result: negative
Remarks: Based on data from similar materials

12 / 19

SAFETY DATA SHEET

Lynestrenol Formulation
Version
9.0

Revision Date:
2024/04/06

SDS Number:
449552-00019

Date of last issue: 2023/09/30
Date of first issue: 2016/01/15

STOT - single exposure
Not classified based on available information.
STOT - repeated exposure
May cause damage to organs (Blood, Mammary gland, Uterus (including cervix), Ovary) throughprolonged or repeated exposure.
Components:
Lynestrenol:
Target Organs
Assessment::

Blood, Mammary gland, Uterus (including cervix), Ovary
Causes damage to organs through prolonged or repeatedexposure.

Starch:Species
NOAEL
Application RouteExposure time
Method

:
:
:
:
:

Rat
>= 2,000 mg/kg
Skin contact
28 Days
OECD Test Guideline 410

Tocopherol:
Species
NOAEL
Application RouteExposure time
Remarks

:
:
:
:
:

Rat
500 mg/kg
Ingestion
90 DaysBased on data from similar materials

Repeated dose toxicity
Components:

Aspiration toxicity
Not classified based on available information.
Experience with human exposure
Components:
Lynestrenol:
Ingestion:

Target Organs: Uterus (including cervix)
Target Organs: breasts
Target Organs: ovaries
Target Organs: Blood
Symptoms: Headache, Nausea, Abdominal pain, Rash, Dizziness, Tremors, Sweating, Vomiting, migraine, acne, breast
tenderness, gynecomastia, menstrual irregularities, ovariancysts
13 / 19

SAFETY DATA SHEET

Lynestrenol Formulation
Version
9.0

Revision Date:
2024/04/06

SDS Number:
449552-00019

Date of last issue: 2023/09/30
Date of first issue: 2016/01/15

Remarks: Used to prevent pregnancy
12. ECOLOGICAL INFORMATION
Ecotoxicity
Components:
Talc:
Toxicity to fish:

LC50 (Brachydanio rerio (zebrafish)): > 100,000 mg/l
Exposure time: 24 h

Tocopherol:
Toxicity to fish:

LC50 (Oncorhynchus mykiss (rainbow trout)): > 100 mg/l
Exposure time: 96 h
Method: OECD Test Guideline 203
Remarks: Based on data from similar materials

Toxicity to daphnia and otheraquatic invertebrates:

EC50 (Daphnia magna (Water flea)): > 23.53 mg/l
Exposure time: 48 h
Method: OECD Test Guideline 202
Remarks: No toxicity at the limit of solubility

Toxicity to algae/aquaticplants:NOEC (Pseudokirchneriella subcapitata (green algae)): 25.8
mg/l
Exposure time: 72 h
Method: OECD Test Guideline 201
Remarks: No toxicity at the limit of solubility
EC50 (Pseudokirchneriella subcapitata (green algae)): > 25.8
mg/l
Exposure time: 72 h
Method: OECD Test Guideline 201
Remarks: No toxicity at the limit of solubility

Toxicity to fish (Chronic toxicity):

NOEC (Oncorhynchus mykiss (rainbow trout)): > 100 mg/l
Exposure time: 28 d
Remarks: Based on data from similar materials

Toxicity to microorganisms:

EC50: > 937 mg/l
Exposure time: 30 min
Method: ISO 8192
Remarks: Based on data from similar materials

Persistence and degradability
Components:
Tocopherol:
Biodegradability:

Result: Not readily biodegradable.
14 / 19

SAFETY DATA SHEET

Lynestrenol Formulation
Version
9.0

Revision Date:
2024/04/06

SDS Number:
449552-00019

Date of last issue: 2023/09/30
Date of first issue: 2016/01/15

Biodegradation: 20 %Exposure time: 28 d
Method: OECD Test Guideline 301F
Bioaccumulative potential
No data available
Mobility in soil
No data available
Hazardous to the ozone layer
Not applicable
Other adverse effects
No data available
13. DISPOSAL CONSIDERATIONS
Disposal methods
Waste from residues:

Contaminated packaging:

Dispose of in accordance with local regulations.
Do not dispose of waste into sewer.
Empty containers should be taken to an approved waste handling site for recycling or disposal.
If not otherwise specified: Dispose of as unused product.

:
:
:
:
:
:
:

Not applicableNot applicableNot applicableNot applicableNot applicableNot applicable
no

:
:
:
:
:
:
:

Not applicableNot applicableNot applicableNot applicableNot applicableNot applicableNot applicable:Not applicable::Not applicableNot applicable

14. TRANSPORT INFORMATIONInternational Regulations
UNRTDGUN number
Proper shipping nameClass
Subsidiary risk
Packing group
LabelsEnvironmentally hazardous
IATA-DGR
UN/ID No.
Proper shipping nameClass
Subsidiary risk
Packing group
LabelsPacking instruction (cargo
aircraft)Packing instruction (passenger aircraft)
IMDG-CodeUN number
Proper shipping name15 / 19

SAFETY DATA SHEET

Lynestrenol Formulation
Version
9.0

Revision Date:
2024/04/06

Class
Subsidiary risk
Packing group
LabelsEmS Code
Marine pollutant

SDS Number:
449552-00019

:
:
:
:
:
:

Date of last issue: 2023/09/30
Date of first issue: 2016/01/15

Not applicableNot applicableNot applicableNot applicableNot applicableNot applicable

Transport in bulk according to Annex II of MARPOL 73/78 and the IBC CodeNot applicable for product as supplied.
National Regulations
Refer to section 15 for specific national regulation.
Special precautions for user
Not applicable
15. REGULATORY INFORMATION
Related Regulations
Fire Service Law
Not applicable to dangerous materials / designated flammables.
Chemical Substance Control Law
Not applicable for Specified Chemical Substance, Monitoring Chemical Substance and Priority
Assessment Chemical Substance.
Industrial Safety and Health Law
Harmful Substances Prohibited from Manufacture
Not applicable
Harmful Substances Required Permission for Manufacture
Not applicable
Substances Prevented From Impairment of Health
Not applicable
Circular concerning Information on Chemicals having Mutagenicity - Annex 2: Information
on Existing Chemicals having Mutagenicity
Not applicable
Circular concerning Information on Chemicals having Mutagenicity - Annex 1: Information
on Notified Substances having Mutagenicity
Not applicable
Substances Subject to be Notified Names
Article 57-2 (Enforcement Order Table 9)
Chemical nameTalc (Mg3H2(SiO3)4) (without asbestos
and quartz)

Concentration (%)>0 - <10

Substances Subject to be Indicated Names
Article 57 (Enforcement Order Article 18)
16 / 19

Remarks
From April 1st, 2025

SAFETY DATA SHEET

Lynestrenol Formulation
Version
9.0

Revision Date:
2024/04/06

SDS Number:
449552-00019

Date of last issue: 2023/09/30
Date of first issue: 2016/01/15

Chemical nameTalc (Mg3H2(SiO3)4)Remarks
From April 1st, 2025

Carcinogenic Substances (Article 577-2 of the Occupational Health and Safety Regulations)Not applicable
Ordinance on Prevention of Hazards Due to Specified Chemical Substances
Not applicable
Ordinance on Prevention of Lead Poisoning
Not applicable
Ordinance on Prevention of Tetraalkyl Lead Poisoning
Not applicable
Ordinance on Prevention of Organic Solvent Poisoning
Not applicable
Enforcement Order of the Industrial Safety and Health Law - Attached table 1 (Dangerous
Substances)
Not applicable
Poisonous and Deleterious Substances Control Law
Not applicable
Act on Confirmation, etc. of Release Amounts of Specific Chemical Substances in the Environment and Promotion of Improvements to the Management Thereof
Not applicable
High Pressure Gas Safety Act
Not applicable
Explosive Control Law
Not applicable
Vessel Safety Law
Not regulated as a dangerous good
Aviation Law
Not regulated as a dangerous goodMarine Pollution and Sea Disaster Prevention etc Law
Bulk transportation:

Not classified as noxious liquid substance

Pack transportation:

Not classified as marine pollutant

Narcotics and Psychotropics Control Act
Narcotic or Psychotropic Raw Material (Export / Import Permission)
Not applicableSpecific Narcotic or Psychotropic Raw Material (Export / Import permission)
Not applicable
Waste Disposal and Public Cleansing Law
Industrial waste

17 / 19

SAFETY DATA SHEET

Lynestrenol Formulation
Version
9.0

Revision Date:
2024/04/06

SDS Number:
449552-00019

Date of last issue: 2023/09/30
Date of first issue: 2016/01/15

The components of this product are reported in the following inventories:
AICS: not determinedDSL:

not determined

IECSC

:

not determined

16. OTHER INFORMATIONIn this SDS, if the concentration of substances subject to notification under the Industrial Safety
and Health Law is indicated as a range, it includes cases where it is a trade secret.
Further information
Sources of key data used tocompile the Safety Data
Sheet

:

Internal technical data, data from raw material SDSs, OECD
eChem Portal search results and European Chemicals Agency, http://echa.europa.eu/

Items where changes have been made to the previous version are highlighted in the body of thisdocument by two vertical lines.
Date format:

yyyy/mm/dd

Full text of other abbreviations
ACGIH: USA. ACGIH Threshold Limit Values (TLV)
JP OEL JSOH
: Japan. The Japan Society for Occupational Health. Recommendation of Occupational Exposure Limits
ACGIH / TWA
JP OEL JSOH / OEL-M::

8-hour, time-weighted average
Occupational Exposure Limit-Mean

AIIC - Australian Inventory of Industrial Chemicals; ANTT - National Agency for Transport byLand of Brazil; ASTM - American Society for the Testing of Materials; bw - Body weight; CMR Carcinogen, Mutagen or Reproductive Toxicant; DIN - Standard of the German Institute forStandardisation; DSL - Domestic Substances List (Canada); ECx - Concentration associated with
x% response; ELx - Loading rate associated with x% response; EmS - Emergency Schedule;
ENCS - Existing and New Chemical Substances (Japan); ErCx - Concentration associated with
x% growth rate response; ERG - Emergency Response Guide; GHS - Globally Harmonized System; GLP - Good Laboratory Practice; IARC - International Agency for Research on Cancer; IATA
- International Air Transport Association; IBC - International Code for the Construction andEquipment of Ships carrying Dangerous Chemicals in Bulk; IC50 - Half maximal inhibitory concentration; ICAO - International Civil Aviation Organization; IECSC - Inventory of Existing Chemical Substances in China; IMDG - International Maritime Dangerous Goods; IMO - International
Maritime Organization; ISHL - Industrial Safety and Health Law (Japan); ISO - International Organisation for Standardization; KECI - Korea Existing Chemicals Inventory; LC50 - Lethal Concentration to 50 % of a test population; LD50 - Lethal Dose to 50% of a test population (Median
Lethal Dose); MARPOL - International Convention for the Prevention of Pollution from Ships;
n.o.s. - Not Otherwise Specified; Nch - Chilean Norm; NO(A)EC - No Observed (Adverse) EffectConcentration; NO(A)EL - No Observed (Adverse) Effect Level; NOELR - No Observable EffectLoading Rate; NOM - Official Mexican Norm; NTP - National Toxicology Program; NZIoC - New
Zealand Inventory of Chemicals; OECD - Organization for Economic Co-operation and Development; OPPTS - Office of Chemical Safety and Pollution Prevention; PBT - Persistent, Bioaccumu18 / 19

SAFETY DATA SHEET

Lynestrenol Formulation
Version
9.0

Revision Date:
2024/04/06

SDS Number:
449552-00019

Date of last issue: 2023/09/30
Date of first issue: 2016/01/15

lative and Toxic substance; PICCS - Philippines Inventory of Chemicals and Chemical Substances; (Q)SAR - (Quantitative) Structure Activity Relationship; REACH - Regulation (EC) No
1907/2006 of the European Parliament and of the Council concerning the Registration, Evaluation, Authorisation and Restriction of Chemicals; SADT - Self-Accelerating Decomposition Temperature; SDS - Safety Data Sheet; TCSI - Taiwan Chemical Substance Inventory; TDG - Transportation of Dangerous Goods; TECI - Thailand Existing Chemicals Inventory; TSCA - Toxic Substances Control Act (United States); UN - United Nations; UNRTDG - United Nations Recommendations on the Transport of Dangerous Goods; vPvB - Very Persistent and Very Bioaccumulative; WHMIS - Workplace Hazardous Materials Information System
The information provided in this Safety Data Sheet is correct to the best of our knowledge, information and belief at the date of its publication. The information is designed only as a guidance forsafe handling, use, processing, storage, transportation, disposal and release and shall not be
considered a warranty or quality specification of any type. The information provided relates only
to the specific material identified at the top of this SDS and may not be valid when the SDS material is used in combination with any other materials or in any process, unless specified in the text.
Material users should review the information and recommendations in the specific context of theirintended manner of handling, use, processing and storage, including an assessment of the appropriateness of the SDS material in the user’s end product, if applicable.
JP / EN

19 / 19